Moderna seeks regulatory approval for its COVID-19 vaccine

Mumbai-based pharmaceutical firm Cipla, on behalf of the U.S. pharma major, has requested for import and marketing authorisation of these jabs

India’s drug regulator may soon grant restricted emergency use authorisation for Moderna’s COVID-19 vaccine, official sources said on June 29. Moderna has also informed that the U.S. Government has agreed to donate a certain number of doses of the Moderna COVID-19 vaccine through COVAX to the Government of India for use and has sought approval from the Central Drugs Standard Control Organisation (CDSCO) for these vaccines. Mumbai-based pharmaceutical firm Cipla, on behalf of the U.S. pharma major, has requested for import and marketing authorisation of these jabs.